摘要
以《国家重点保护野生药材物种名录》、《国家重点保护野生动物名录》、《国家重点保护野生植物名录(第一批)》、华盛顿公约(CITES)附录1和附录2等名录中收载且具有法定药材标准的动植物物种所对应的药材品种作为国家重点保护野生药材,对其在我国中成药质量标准"处方"项下出现的频次进行了查询,并结合相关药材人工栽培及养殖的文献,对相关重点保护野生药材在中成药中的应用状况进行初步分析,为其可持续利用提供参考。
As state key-protected wild medicinal materials, their species are collected in State Key-protected Wild Medicinal Species List, State Key-protected Wild Animals List, and State Key-protected Wild Plants List （the first） and Convention on International Trade in Endangered Species of Wild Fauna and Flora （CITES） Appendix I/II, and there are legal medicinal material standards. Based on the statistical results of the existence frequency in Chinese patent medicine and the literatures of medicinal materials cultivation and breeding situation, the application of key-protected wild medicinal materials is preliminarily estimated, which would provide the reference for their sustainable utilization.
出处
《中草药》
CAS
CSCD
北大核心
2013年第5期505-514,共10页
Chinese Traditional and Herbal Drugs
关键词
重点保护野生药材
中成药
处方
质量标准
栽培与养殖
key-protected wild medicinal materials
Chinese patent medicine
formulation
quality standard
cultivation and breeding
